For: | Sun L, Guan YS, Pan WM, Chen GB, Luo ZM, Wei JH, Wu H. Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma. World J Gastroenterol 2008; 14(8): 1212-1217 [PMID: 18300346 DOI: 10.3748/wjg.14.1212] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i8/1212.htm |
Number | Citing Articles |
1 |
Thibault Fidani, Guillaume Desmarets, Jean Goupil, Jean-Pierre Pouget, Vincent Boudousq. A Recanalized Umbilical Vein Hypermetabolic Thrombosis Mimicked an Hepatocellular Carcinoma Recurrence. Clinical Nuclear Medicine 2022; 47(7): 640 doi: 10.1097/RLU.0000000000004133
|
2 |
Y. CHAWLA, A. DUSEJA, R. K. DHIMAN. Review article: the modern management of portal vein thrombosis. Alimentary Pharmacology & Therapeutics 2009; 30(9): 881 doi: 10.1111/j.1365-2036.2009.04116.x
|
3 |
Krishan Kant Agarwal, Dipalkumar Shah, Neha Shah, Manas Mayank. Differentiation of Malignant Thrombus From Bland Thrombus of the Portal Vein in Patient With Hepatocellular Carcinoma on 18F-FDG PET CT. Clinical Nuclear Medicine 2017; 42(11): e472 doi: 10.1097/RLU.0000000000001840
|
4 |
Sameh Abokoura, Heba Said Ellaban, Rasha Abdelhafiz Aly. The role of 18F-FDG PET/CT in distinguishing benign from malignant portal vein thrombosis. Egyptian Journal of Radiology and Nuclear Medicine 2023; 54(1) doi: 10.1186/s43055-023-01058-1
|
5 |
Cher Heng Tan, Su-Chong Albert Low, Choon Hua Thng. APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review. International Journal of Hepatology 2011; 2011: 1 doi: 10.4061/2011/519783
|
6 |
|
7 |
Chun-Yi Lin, Jin-Hua Chen, Ji-An Liang, Cheng-Chieh Lin, Long-Bin Jeng, Chia-Hung Kao. 18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: A systematic review and meta-analysis. European Journal of Radiology 2012; 81(9): 2417 doi: 10.1016/j.ejrad.2011.08.004
|
8 |
Vladimir M. Subbotin. Privileged portal metastasis of hepatocellular carcinoma in light of co-evolution of a visceral portal system and the liver in the chordate lineage: a search for therapeutic targets. Drug Discovery Today 2018; 23(3): 548 doi: 10.1016/j.drudis.2018.01.020
|
9 |
Søren Hess, Poul Henning Madsen, Sandip Basu, Poul Flemming Høilund-Carlsen, Abass Alavi. Potential Role of FDG PET/CT Imaging for Assessing Venous Thromboembolic Disorders. Clinical Nuclear Medicine 2012; 37(12): 1170 doi: 10.1097/RLU.0b013e318279bf73
|
10 |
Hyuk Jae Jung, Sang Su Lee. Combination of Surgical Thrombectomy and Direct Thrombolysis in Acute Abdomen with Portal and Superior Mesenteric Vein Thrombosis. Vascular Specialist International 2014; 30(4): 155 doi: 10.5758/vsi.2014.30.4.155
|
11 |
Vladimir M. Subbotin. A hypothesis on paradoxical privileged portal vein metastasis of hepatocellular carcinoma. Can organ evolution shed light on patterns of human pathology, and vice versa?. Medical Hypotheses 2019; 126: 109 doi: 10.1016/j.mehy.2019.03.019
|
12 |
Bing Wu, Yiqiu Zhang, Hui Tan, Hongcheng Shi. Value of 18F-FDG PET/CT in the diagnosis of portal vein tumor thrombus in patients with hepatocellular carcinoma. Abdominal Radiology 2019; 44(7): 2430 doi: 10.1007/s00261-019-01997-2
|
13 |
Tyler J. Fraum, Daniel R. Ludwig, Thomas A. Hope, Kathryn J. Fowler. PET/MRI for Gastrointestinal Imaging. Gastroenterology Clinics of North America 2018; 47(3): 691 doi: 10.1016/j.gtc.2018.04.011
|
14 |
Sascha Kaufmann, Maximilian Schulze, Daniel Spira, Marius Horger. Modern multimodality diagnosis of portal vein infiltration in hepatocellular carcinoma and expected changes during current therapies. Acta Radiologica 2015; 56(11): 1283 doi: 10.1177/0284185114556305
|
15 |
Yasuo Sakamoto, Shigeki Nakagawa, Shinya Abe, Daisuke Hashimoto, Akira Chikamoto, Masayuki Watanabe, Toru Beppu, Hideo Baba. Widespread portal venous thrombosis in a patient with pancreatic cancer. International Cancer Conference Journal 2014; 3(4): 237 doi: 10.1007/s13691-014-0154-x
|
16 |
Khangembam Bangkim Chandra, Abhinav Singhal. Predictors of Macrovascular Invasion and Extrahepatic Metastasis in Treatment Naive Hepatocellular Carcinoma: When Is [18F] FDG PET/CT Relevant?. Nuclear Medicine and Molecular Imaging 2021; 55(6): 293 doi: 10.1007/s13139-021-00714-6
|
17 |
Aurora Sainz-Esteban, Vikas Prasad, Richard P. Baum. Pancreatic Neuroendocrine Tumor With Involvement of the Inferior Mesenteric Vein Diagnosed by Ga-68 DOTA-TATE PET/CT. Clinical Nuclear Medicine 2010; 35(1): 40 doi: 10.1097/RLU.0b013e3181c3b74a
|
18 |
Pankaj Handa, Mark Crowther, James D. Douketis. Portal Vein Thrombosis. Clinical and Applied Thrombosis/Hemostasis 2014; 20(5): 498 doi: 10.1177/1076029612473515
|
19 |
Archi Agrawal, Nilendu Purandare, Sneha Shah, Ameya Puranik, Venkatesh Rangarajan. Extensive tumor thrombus of hepatocellular carcinoma in the entire portal venous system detected on fluorodeoxyglucose positron emission tomography computed tomography. Indian Journal of Nuclear Medicine 2013; 28(1): 54 doi: 10.4103/0972-3919.116805
|
20 |
Feng-Yong Liu, Mao-Qiang Wang, Qing-Sheng Fan, Feng Duan, Zhi-Jun Wang, Peng Song. Interventional treatment for symptomatic acute-subacute portal and superior mesenteric vein thrombosis. World Journal of Gastroenterology 2009; 15(40): 5028-5034 doi: 10.3748/wjg.15.5028
|
21 |
Shengping Hu, Jian Zhang, Chao Cheng, Qinghua Liu, Gaofeng Sun, Changjing Zuo. The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis. Abdominal Imaging 2014; 39(6): 1221 doi: 10.1007/s00261-014-0170-5
|
22 |
Xilan Yao, Weiting Liu, Xiaohong Ou. 68Ga-FAPI PET/MRI and 18F-FDG PET/CT in a Case With Extensive Portal Vein Tumor Thrombus. Clinical Nuclear Medicine 2023; 48(4): 373 doi: 10.1097/RLU.0000000000004579
|
23 |
Yogesh K. Chawla, Vijay Bodh. Portal Vein Thrombosis. Journal of Clinical and Experimental Hepatology 2015; 5(1): 22 doi: 10.1016/j.jceh.2014.12.008
|
24 |
María Trinidad Fernández Sarabia, Jose Manuel Rodríguez García, Antonio Cardenal Escarcena, Justo Serrano Vicente, Lucía García Bernardo. Adrenal metastasis of breast cancer with involvement of the inferior vena cava. Clinical and Translational Oncology 2008; 10(11): 761 doi: 10.1007/s12094-008-0284-8
|
25 |
Long Sun, Yong-Song Guan, Wei-Min Pan, Zuo-Ming Luo, Ji-Hong Wei, Long Zhao, Hua Wu. Metabolic restaging of hepatocellular carcinoma using whole-body <sup>18</sup>F-FDG PET/CT. World Journal of Hepatology 2009; 1(1): 90-97 doi: 10.4254/wjh.v1.i1.90
|
26 |
Guillaume Chausse, Gad Abikhzer, Stephan Probst, Jerome Laufer.
18F-fluorodeoxyglucose positron emission tomography/computed tomography in extensive bland portal vein thrombosis from retroperitoneal adenocarcinoma. World Journal of Nuclear Medicine 2019; 18(02): 192 doi: 10.4103/wjnm.wjnm_8_18
|
27 |
Raluca Mititelu, Alexandru Mitoi, Catalin Mazilu, Mariana Jinga, Florentina Ionita Radu, Ana Bucurica, Teodora Mititelu, Sandica Bucurica. Advancements in hepatocellular carcinoma management: the role of 18F-FDG PET-CT in diagnosing portal vein tumor thrombosis. Nuclear Medicine Communications 2024; 45(8): 651 doi: 10.1097/MNM.0000000000001863
|
28 |
Jeong Won Lee, Sang Hyun Hwang, Do Young Kim, Kwang-Hyub Han, Mijin Yun. Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma. Clinical Nuclear Medicine 2017; 42(1): e35 doi: 10.1097/RLU.0000000000001422
|